Dual-targeted therapy shows promise against metastatic triple-negative breast cancer
A new preclinical study suggests that attacking triple-negative breast cancer (TNBC) in two ways at once can kill cancer cells, slow tumor growth and limit the cancer’s spread. Researchers at…